Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:levothyroxine_sodium
|
| gptkbp:ATCCode |
H03AA01
|
| gptkbp:contraindication |
gptkb:thyrotoxicosis
untreated adrenal insufficiency |
| gptkbp:drugClass |
hormone
|
| gptkbp:FDAApproved |
yes
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericAvailable |
yes
|
| https://www.w3.org/2000/01/rdf-schema#label |
Levoxyl
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:pregnancyCategory |
A
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
anxiety
weight loss insomnia palpitations increased appetite |
| gptkbp:usedFor |
hypothyroidism
thyroid hormone replacement |
| gptkbp:bfsParent |
gptkb:King_Pharmaceuticals
|
| gptkbp:bfsLayer |
5
|